Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76


SGEF forms a complex with Scribble and Dlg1 and regulates epithelial junctions and contractility.

Awadia S, Huq F, Arnold TR, Goicoechea SM, Sun YJ, Hou T, Kreider-Letterman G, Massimi P, Banks L, Fuentes EJ, Miller AL, Garcia-Mata R.

J Cell Biol. 2019 Aug 5;218(8):2699-2725. doi: 10.1083/jcb.201811114. Epub 2019 Jun 27.


Diverse Papillomavirus Types Induce Endosomal Tubulation.

Siddiqa A, Massimi P, Pim D, Banks L.

Front Cell Infect Microbiol. 2019 May 28;9:175. doi: 10.3389/fcimb.2019.00175. eCollection 2019.


The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells.

Basukala O, Mittal S, Massimi P, Bestagno M, Banks L.

PLoS Pathog. 2019 May 22;15(5):e1007769. doi: 10.1371/journal.ppat.1007769. eCollection 2019 May.


Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Broniarczyk J, Massimi P, Pim D, Bergant Marušič M, Myers MP, Garcea RL, Banks L.

J Virol. 2019 Jun 14;93(13). pii: e00128-19. doi: 10.1128/JVI.00128-19. Print 2019 Jul 1.


Oncogenic comparison of human papillomavirus type 58 E7 variants.

Law PT, Boon SS, Hu C, Lung RW, Cheung GP, Ho WC, Chen Z, Massimi P, Thomas M, Pim D, Banks L, Chan PK.

J Cell Mol Med. 2019 Feb;23(2):1517-1527. doi: 10.1111/jcmm.14059. Epub 2018 Dec 21.


The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.

Thatte J, Massimi P, Thomas M, Boon SS, Banks L.

J Virol. 2018 Jul 31;92(16). pii: e00465-18. doi: 10.1128/JVI.00465-18. Print 2018 Aug 15.


HPV-16 virions can remain infectious for 2 weeks on senescent cells but require cell cycle re-activation to allow virus entry.

Broniarczyk J, Ring N, Massimi P, Giacca M, Banks L.

Sci Rep. 2018 Jan 16;8(1):811. doi: 10.1038/s41598-017-18809-6.


Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.

Siddiqa A, Massimi P, Pim D, Broniarczyk J, Banks L.

J Virol. 2018 Feb 26;92(6). pii: e01514-17. doi: 10.1128/JVI.01514-17. Print 2018 Mar 15.


The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines.

Kranjec C, Tomaić V, Massimi P, Nicolaides L, Doorbar J, Banks L.

Papillomavirus Res. 2016 Dec;2:70-77. doi: 10.1016/j.pvr.2016.04.001. Epub 2016 Apr 7.


The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly.

Broniarczyk J, Pim D, Massimi P, Bergant M, Goździcka-Józefiak A, Crump C, Banks L.

Sci Rep. 2017 Mar 28;7:45159. doi: 10.1038/srep45159.


Monitoring HPV-16 E7 phosphorylation events.

Nogueira MO, Hošek T, Calçada EO, Castiglia F, Massimi P, Banks L, Felli IC, Pierattelli R.

Virology. 2017 Mar;503:70-75. doi: 10.1016/j.virol.2016.12.030. Epub 2017 Jan 23.


The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.

Szalmás A, Tomaić V, Basukala O, Massimi P, Mittal S, Kónya J, Banks L.

J Virol. 2017 Mar 13;91(7). pii: e00057-17. doi: 10.1128/JVI.00057-17. Print 2017 Apr 1.


A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.

Zine El Abidine A, Tomaić V, Bel Haj Rhouma R, Massimi P, Guizani I, Boubaker S, Ennaifer E, Banks L.

Virology. 2017 Jan;500:218-225. doi: 10.1016/j.virol.2016.10.023. Epub 2016 Nov 6.


Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways.

Ganti K, Massimi P, Manzo-Merino J, Tomaić V, Pim D, Playford MP, Lizano M, Roberts S, Kranjec C, Doorbar J, Banks L.

PLoS Pathog. 2016 Sep 20;12(9):e1005854. doi: 10.1371/journal.ppat.1005854. eCollection 2016 Sep.


Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential.

Thomas M, Myers MP, Massimi P, Guarnaccia C, Banks L.

PLoS Pathog. 2016 Aug 2;12(8):e1005766. doi: 10.1371/journal.ppat.1005766. eCollection 2016 Aug.


The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.

Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaić V, Banks L.

Viruses. 2015 Jul 2;7(7):3530-51. doi: 10.3390/v7072785. Review.


Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process.

Broniarczyk J, Massimi P, Bergant M, Banks L.

J Virol. 2015 Sep;89(17):8727-32. doi: 10.1128/JVI.00722-15. Epub 2015 Jun 10.


High risk HPV E6 oncoproteins impair the subcellular distribution of the four and a half LIM-only protein 2 (FHL2).

Manzo-Merino J, Massimi P, Banks L, Lizano M.

Virology. 2015 Feb;476:100-105. doi: 10.1016/j.virol.2014.11.025. Epub 2014 Dec 23.


Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.

Kranjec C, Massimi P, Banks L.

J Virol. 2014 Jul;88(13):7155-69. doi: 10.1128/JVI.03247-13. Epub 2014 Apr 2.


The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.

Manzo-Merino J, Massimi P, Lizano M, Banks L.

Virology. 2014 Feb;450-451:146-52. doi: 10.1016/j.virol.2013.12.013. Epub 2013 Dec 31.


Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.

Facciuto F, Bugnon Valdano M, Marziali F, Massimi P, Banks L, Cavatorta AL, Gardiol D.

Mol Oncol. 2014 May;8(3):533-43. doi: 10.1016/j.molonc.2014.01.002. Epub 2014 Jan 14.


Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation.

Cohen MJ, Yousef AF, Massimi P, Fonseca GJ, Todorovic B, Pelka P, Turnell AS, Banks L, Mymryk JS.

J Virol. 2013 Sep;87(18):10348-55. doi: 10.1128/JVI.00786-13. Epub 2013 Jul 17.


A novel interaction between hScrib and PP1γ downregulates ERK signaling and suppresses oncogene-induced cell transformation.

Nagasaka K, Seiki T, Yamashita A, Massimi P, Subbaiah VK, Thomas M, Kranjec C, Kawana K, Nakagawa S, Yano T, Taketani Y, Fujii T, Kozuma S, Banks L.

PLoS One. 2013;8(1):e53752. doi: 10.1371/journal.pone.0053752. Epub 2013 Jan 24.


Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.

Todorovic B, Hung K, Massimi P, Avvakumov N, Dick FA, Shaw GS, Banks L, Mymryk JS.

J Virol. 2012 Dec;86(24):13313-23. doi: 10.1128/JVI.01637-12. Epub 2012 Sep 26.


Human papillomaviruses and the specificity of PDZ domain targeting.

Pim D, Bergant M, Boon SS, Ganti K, Kranjec C, Massimi P, Subbaiah VK, Thomas M, Tomaić V, Banks L.

FEBS J. 2012 Oct;279(19):3530-3537. doi: 10.1111/j.1742-4658.2012.08709.x. Epub 2012 Aug 29. Review.


Differential regulation of cell-cell contact, invasion and anoikis by hScrib and hDlg in keratinocytes.

Massimi P, Zori P, Roberts S, Banks L.

PLoS One. 2012;7(7):e40279. doi: 10.1371/journal.pone.0040279. Epub 2012 Jul 6.


A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells.

Macdonald AI, Sun P, Hernandez-Lopez H, Aasen T, Hodgins MB, Edward M, Roberts S, Massimi P, Thomas M, Banks L, Graham SV.

Biochem J. 2012 Aug 15;446(1):9-21. doi: 10.1042/BJ20111144.


Regulation of the DLG tumor suppressor by β-catenin.

Subbaiah VK, Narayan N, Massimi P, Banks L.

Int J Cancer. 2012 Nov 15;131(10):2223-33. doi: 10.1002/ijc.27519. Epub 2012 Mar 28.


The invasive capacity of HPV transformed cells requires the hDlg-dependent enhancement of SGEF/RhoG activity.

Krishna Subbaiah V, Massimi P, Boon SS, Myers MP, Sharek L, Garcia-Mata R, Banks L.

PLoS Pathog. 2012 Feb;8(2):e1002543. doi: 10.1371/journal.ppat.1002543. Epub 2012 Feb 23.


Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.

Todorovic B, Massimi P, Hung K, Shaw GS, Banks L, Mymryk JS.

J Virol. 2011 Oct;85(19):10048-57. doi: 10.1128/JVI.00643-11. Epub 2011 Jul 20.


The mechanism and implications of hScrib regulation of ERK.

Nagasaka K, Massimi P, Pim D, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Banks L.

Small GTPases. 2010 Sep;1(2):108-112.


Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.

Tomaic V, Pim D, Thomas M, Massimi P, Myers MP, Banks L.

J Virol. 2011 Apr;85(7):3120-7. doi: 10.1128/JVI.02004-10. Epub 2011 Jan 12.


The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction.

Nagasaka K, Pim D, Massimi P, Thomas M, Tomaić V, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Myers M, Banks L.

Oncogene. 2010 Sep 23;29(38):5311-21. doi: 10.1038/onc.2010.265. Epub 2010 Jul 12.


CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability.

Narayan N, Massimi P, Banks L.

J Cell Sci. 2009 Jan 1;122(Pt 1):65-74. doi: 10.1242/jcs.024554. Epub 2008 Dec 9.


Human papillomaviruses, cervical cancer and cell polarity.

Thomas M, Narayan N, Pim D, Tomaić V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L.

Oncogene. 2008 Nov 24;27(55):7018-30. doi: 10.1038/onc.2008.351. Review.


The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2.

Gammoh N, Gardiol D, Massimi P, Banks L.

J Virol. 2009 Feb;83(3):1538-43. doi: 10.1128/JVI.01551-08. Epub 2008 Nov 12.


Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.

Tomaić V, Gardiol D, Massimi P, Ozbun M, Myers M, Banks L.

Oncogene. 2009 Jan 8;28(1):1-8. doi: 10.1038/onc.2008.365. Epub 2008 Sep 29.


Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complex.

Massimi P, Narayan N, Thomas M, Gammoh N, Strand S, Strand D, Banks L.

Exp Cell Res. 2008 Nov 1;314(18):3306-17. doi: 10.1016/j.yexcr.2008.08.016. Epub 2008 Sep 3.


Targeting the retinoblastoma protein by MC007L, gene product of the molluscum contagiosum virus: detection of a novel virus-cell interaction by a member of the poxviruses.

Mohr S, Grandemange S, Massimi P, Darai G, Banks L, Martinou JC, Zeier M, Muranyi W.

J Virol. 2008 Nov;82(21):10625-33. doi: 10.1128/JVI.01187-08. Epub 2008 Aug 13.


Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer.

Massimi P, Thomas M, Bouvard V, Ruberto I, Campo MS, Tommasino M, Banks L.

Virology. 2008 Feb 20;371(2):374-9. Epub 2007 Nov 13.


HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.

Massimi P, Shai A, Lambert P, Banks L.

Oncogene. 2008 Mar 13;27(12):1800-4. Epub 2007 Oct 15.


Transformation assays for HPV oncoproteins.

Massimi P, Banks L.

Methods Mol Med. 2005;119:381-95.


The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins.

Thomas M, Massimi P, Navarro C, Borg JP, Banks L.

Oncogene. 2005 Sep 15;24(41):6222-30.


Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.

Grm HS, Massimi P, Gammoh N, Banks L.

Oncogene. 2005 Aug 4;24(33):5149-64.


Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.

Stewart D, Kazemi S, Li S, Massimi P, Banks L, Koromilas AE, Matlashewski G.

J Gen Virol. 2004 Jun;85(Pt 6):1419-26.


Redistribution of the discs large tumor suppressor protein during mitosis.

Massimi P, Gardiol D, Roberts S, Banks L.

Exp Cell Res. 2003 Nov 1;290(2):265-74.


Supplemental Content

Loading ...
Support Center